Search - tctmd.com

Displaying 761 - 780 of 1554

Sort: Relevancy | Date

Presentation TCT 2019

Post-CABG Localized Tamponade: Prevention, Identification, and Management

Presenter: Robert Riley

September 28, 2019

Presentation TCT 2019

Septal Collateral Perforations: Prevention and Management

Presenter: Roberto Garbo

September 28, 2019

Presentation TCT 2019

Antegrade Wire or Device Exit at the CTO Site: Prevention and Management

Presenter: Nicholas Lembo

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Presenter: Bon-Kwon Koo

September 27, 2019

Presentation TCT 2019

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: Ryan Madder

September 27, 2019

Presentation TCT 2019

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: James Min

September 27, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Presentation TCT 2019

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Presenter: Seung-Jung Park

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

Presenter: Ron Waksman

September 27, 2019

Presentation TCT 2019

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

Presenter: Francesco Prati

September 27, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Presentation TCT 2019

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Tackling Inflammation: Novel Targets

Presenter: Wolfgang Koenig

September 26, 2019

Presentation TCT 2019

LP(a): Not So Little Anymore

Presenter: Roberta Rossini

September 26, 2019

Presentation TCT 2019

Don’t Forget About Your HDL: The AEGIS Program

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

Role of PCSK9 Inhibitors Post-PCI and ACS

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Loading Dose Statin Prior PCI: Is There a Role For It?

Presenter: Renato Lopes

September 26, 2019

Advertisement

Post-CABG Localized Tamponade: Prevention, Identification, and Management

Septal Collateral Perforations: Prevention and Management

Antegrade Wire or Device Exit at the CTO Site: Prevention and Management

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Tackling Inflammation: Novel Targets

LP(a): Not So Little Anymore

Don’t Forget About Your HDL: The AEGIS Program

Role of PCSK9 Inhibitors Post-PCI and ACS

Loading Dose Statin Prior PCI: Is There a Role For It?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content